| Literature DB >> 33275143 |
Kexin Huang1, Tianfan Fu2, Lucas M Glass3, Marinka Zitnik1, Cao Xiao3, Jimeng Sun4.
Abstract
SUMMARY: Accurate prediction of drug-target interactions (DTI) is crucial for drug discovery. Recently, deep learning (DL) models for show promising performance for DTI prediction. However, these models can be difficult to use for both computer scientists entering the biomedical field and bioinformaticians with limited DL experience. We present DeepPurpose, a comprehensive and easy-to-use DL library for DTI prediction. DeepPurpose supports training of customized DTI prediction models by implementing 15 compound and protein encoders and over 50 neural architectures, along with providing many other useful features. We demonstrate state-of-the-art performance of DeepPurpose on several benchmark datasets.Entities:
Mesh:
Substances:
Year: 2021 PMID: 33275143 PMCID: PMC8016467 DOI: 10.1093/bioinformatics/btaa1005
Source DB: PubMed Journal: Bioinformatics ISSN: 1367-4803 Impact factor: 6.937
Fig. 1.Overview of DeepPurpose library. (A) DeepPurpose takes as input the SMILES of a compound and a protein’s amino acid sequence and then generates embeddings for them. (B) The learned embeddings are then concatenated and fed into a decoder to predict DTI binding affinity. (C) DeepPurpose provides a simple but flexible programming framework that implements over 50 state-of-the-art DL models for DTI prediction. (D) DeepPurpose models achieve comparable performance with three other DTI prediction algorithms on two benchmark datasets. (E) Finally, DeepPurpose has many functionalities, including monitoring the training process, debugging and generation ranked lists for repurposing and screening. Further, DeepPurpose supports other downstream prediction tasks (e.g. drug–drug interaction prediction, compound property prediction)